The Globe and Mail reports in its Tuesday, Nov. 7, edition that RBC Capital analyst Scott Heleniak has reiterated his "outperform" recommendation for Fairfax Financial Holdings. The Globe's David Leeder writes that Mr. Heleniak elevated his share target to $1,020 (U.S.) from $980 (U.S.). Analysts on average target the shares at $1,590.54 (Canadian). Mr. Heleniak says in a note: "Similar to the past few quarters, Fairfax delivered another quarter of solid results across the organization including underwriting, investments, and non-insurance entities. The company extended its duration to pick up yield in the quarter and that should continue to benefit investment income throughout 2024. P&C market conditions remain favorable for Fairfax particularly within its Odyssey Re unit. While reserve releases were modest and cat losses slightly elevated in Q3, core underwriting margins were better than we had expected." The Globe reported on May 24 that National Bank rated Fairfax "outperform" when it could be had for $956.82 (Canadian). The Globe reported on July 25 that Scotia Capital analyst Phil Hardie had reaffirmed his "sector outperform" for Fairfax which was then trading at $1,023.27 (Canadian).